John R Smethells1, Danielle Burroughs2, Amy Saykao2, Paul R Pentel3, Amir H Rezvani4, Mark G LeSage5. 1. Hennepin Healthcare Research Institute, Minneapolis, MN, United States; Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, United States. 2. Hennepin Healthcare Research Institute, Minneapolis, MN, United States. 3. Hennepin Healthcare Research Institute, Minneapolis, MN, United States; Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, United States; Department of Pharmacology, University of Minnesota Medical School, Minneapolis, MN, United States. 4. Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, United States. 5. Hennepin Healthcare Research Institute, Minneapolis, MN, United States; Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, United States; Department of Pharmacology, University of Minnesota Medical School, Minneapolis, MN, United States; Department of Psychology, University of Minnesota, Minneapolis, MN, United States. Electronic address: lesag002@umn.edu.
Abstract
BACKGROUND: The Food and Drug Administration (FDA) is considering setting a nicotine standard for tobacco products to reduce their addictiveness. Such a standard should account for the apparent greater vulnerability to nicotine addiction in some subpopulations, such as adolescents with depression. The present study examined whether the reinforcement threshold and elasticity of demand (i.e., reinforcing efficacy) for nicotine in a genetic inbred rat model of depression (Flinders Sensitive Line [FSL]) differs from an outbred control strain. METHODS: Acquisition of nicotine self-administration (NSA) across a wide range of nicotine doses was measured in both FSL and Sprague-Dawley (SD) control adolescent rats. At the highest dose, elasticity of demand was also measured. Nicotine pharmacokinetics was examined to determine whether it might modulate NSA, as it does smoking in humans. RESULTS: FSL rats acquired self-administration quicker and showed more inelastic demand (greater reinforcing efficacy) than SDs at the highest unit dose. However, there was no strain difference in the reinforcement threshold of nicotine. FSL rats exhibited faster nicotine clearance, larger volume of distribution, and lower plasma and brain nicotine concentrations. However, these differences were not consistently related to strain differences in NSA measures. CONCLUSION: These findings are consistent with studies showing greater dependence and reinforcing efficacy of cigarettes in smokers with depression and those with relatively fast nicotine metabolism. However, these findings also suggest that a nicotine standard to reduce initiation of tobacco use should be similarly effective in both the general adolescent population and those with depression.
BACKGROUND: The Food and Drug Administration (FDA) is considering setting a nicotine standard for tobacco products to reduce their addictiveness. Such a standard should account for the apparent greater vulnerability to nicotine addiction in some subpopulations, such as adolescents with depression. The present study examined whether the reinforcement threshold and elasticity of demand (i.e., reinforcing efficacy) for nicotine in a genetic inbred rat model of depression (Flinders Sensitive Line [FSL]) differs from an outbred control strain. METHODS: Acquisition of nicotine self-administration (NSA) across a wide range of nicotine doses was measured in both FSL and Sprague-Dawley (SD) control adolescent rats. At the highest dose, elasticity of demand was also measured. Nicotine pharmacokinetics was examined to determine whether it might modulate NSA, as it does smoking in humans. RESULTS: FSL rats acquired self-administration quicker and showed more inelastic demand (greater reinforcing efficacy) than SDs at the highest unit dose. However, there was no strain difference in the reinforcement threshold of nicotine. FSL rats exhibited faster nicotine clearance, larger volume of distribution, and lower plasma and brain nicotine concentrations. However, these differences were not consistently related to strain differences in NSA measures. CONCLUSION: These findings are consistent with studies showing greater dependence and reinforcing efficacy of cigarettes in smokers with depression and those with relatively fast nicotine metabolism. However, these findings also suggest that a nicotine standard to reduce initiation of tobacco use should be similarly effective in both the general adolescent population and those with depression.
Authors: Tracy T Smith; Melissa E Levin; Rachel L Schassburger; Deanne M Buffalari; Alan F Sved; Eric C Donny Journal: Nicotine Tob Res Date: 2013-07-01 Impact factor: 4.244
Authors: Patricia Vieyra-Reyes; Yann S Mineur; Marina R Picciotto; Isaac Túnez; Román Vidaltamayo; René Drucker-Colín Journal: Brain Res Bull Date: 2008-06-26 Impact factor: 4.077
Authors: Jennifer O'Loughlin; Joseph DiFranza; Rachel F Tyndale; Garbis Meshefedjian; Elizabeth McMillan-Davey; Paul B S Clarke; James Hanley; Gilles Paradis Journal: Am J Prev Med Date: 2003-10 Impact factor: 5.043
Authors: J R DiFranza; J A Savageau; N A Rigotti; K Fletcher; J K Ockene; A D McNeill; M Coleman; C Wood Journal: Tob Control Date: 2002-09 Impact factor: 7.552
Authors: Kaziya M Lee; Michal A Coelho; Kimberly R Sern; MacKayla A Class; Mark D Bocz; Karen K Szumlinski Journal: Chronic Stress (Thousand Oaks) Date: 2017-06-27